BCYC Bicycle Therapeutics plc
Bicycle Therapeutics plc (BCYC) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 2% planned / 98% discretionary
Largest single sale: $21.4K.
Where they traded
No open-market insider purchase on record.
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Lee Kevin | CHIEF EXECUTIVE OFFICER | Sell | 1,638 | $3.57 | $5.8K | 595,866 −0.3% of holding | |
| Perry Jennifer Scott 2 fills | Chief Operating Officer | Sell 10b5-1 | 652 | $3.78 | $2.5K | 89,602 −0.7% of holding | |
| Skynner Michael | CHIEF SCIENTIFIC OFFICER | Sell | 503 | $3.57 | $1.8K | 154,726 −0.3% of holding | |
| Hannay Michael Charles Ferguson | CHIEF PROD & SUPPLY CHAIN OFF | Sell | 242 | $3.57 | $864 | 92,561 −0.3% of holding | |
| Perry Jennifer Scott 2 fills | Chief Operating Officer | Sell | 110 | $3.56 | $392 | 89,928 −0.1% of holding | |
| Thompson Travis Alvin | Chief Financial Officer | Sell | 79 | $3.57 | $282 | 64,449 −0.1% of holding | |
| Lee Kevin | CHIEF EXECUTIVE OFFICER | Sell | 6,167 | $3.47 | $21.4K | 597,504 −1% of holding | |
| Swanton Robert Charles | Director | Sell | 3,431 | $3.47 | $11.9K | 15,782 −17.9% of holding | |
| Skynner Michael | CHIEF SCIENTIFIC OFFICER | Sell | 1,942 | $3.47 | $6.7K | 155,229 −1.2% of holding | |
| Hannay Michael Charles Ferguson | CHIEF PROD & SUPPLY CHAIN OFF | Sell | 1,572 | $3.47 | $5.5K | 92,803 −1.7% of holding | |
| Perry Jennifer Scott | Chief Operating Officer | Sell | 1,094 | $3.47 | $3.8K | 89,958 −1.2% of holding | |
| Thompson Travis Alvin | Chief Financial Officer | Sell | 893 | $3.47 | $3.1K | 64,528 −1.4% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.